Trial NCT05929716

View at ClinicalTrials.gov 
Org. Study IDs: 2022-1011
Secondary IDs: NCI-2023-05051

Last trial update was posted on 2023-11-13

MeSH Interventions

Magrolimab Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell

Other Conditions

B-cell Lymphoma Large B-cell Lymphoma

Stopping Reasons

Per Principal Investigator request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID